VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics has announced its plan to issue common shares to satisfy interest payments on its convertible debentures, pending approval from the TSXV. Additionally, the company has revised the terms of its convertible debenture offering, adjusting conversion rates over the term’s duration.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.